Study of critically ill patients with COVID-19 in New York City

Affiliations

¹ Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan 20090, Italy.
² Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy. Electronic address: stefanos.bonovas@hunimed.eu.

Comment

Daniele Piovani et al. Lancet. 2020.

. 2020 Oct 10;396(10257):1064.

doi: 10.1016/S0140-6736(20)32072-9.

¹ Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan 20090, Italy.
² Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy. Electronic address: stefanos.bonovas@hunimed.eu.

No abstract available

Comment on

Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study.
Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, Aaron JG, Claassen J, Rabbani LE, Hastie J, Hochman BR, Salazar-Schicchi J, Yip NH, Brodie D, O'Donnell MR. Cummings MJ, et al. Lancet. 2020 Jun 6;395(10239):1763-1770. doi: 10.1016/S0140-6736(20)31189-2. Epub 2020 May 19. Lancet. 2020. PMID: 32442528 Free PMC article.

1. Cummings MJ, Baldwin MR, Abrams D. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395:1763–1770. - PMC - PubMed
1. Bland JM, Altman DG. Survival probabilities (the Kaplan–Meier method) BMJ. 1998;317 - PMC - PubMed
1. Bonovas S, Piovani D. Compassionate use of remdesivir in Covid-19. N Engl J Med. 2020;382:e101. - PubMed